作者
Jan P Vandenbroucke, Jan Rosing, Kitty WM Bloemenkamp, Saskia Middeldorp, Frans M Helmerhorst, Bonno N Bouma, Frits R Rosendaal
发表日期
2001/5/17
来源
New England Journal of Medicine
卷号
344
期号
20
页码范围
1527-1535
出版商
Massachusetts Medical Society
简介
In the early 1960s, shortly after the introduction of oral contraceptives, the first case reports appeared describing venous thrombosis and pulmonary emboli in women using this method of birth control. Later, myocardial infarction and stroke were also found to be associated with the use of oral contraceptives. These observations led to numerous epidemiologic and clinical studies of oral-contraceptive pills and thrombosis and subsequently to the development of new oral contraceptives with a lower estrogen content. These lower-estrogen contraceptives were considered safer: changes in hemostatic factors remained small, inconsistent in direction, and mostly within the normal range.1–4
Recent studies have . . .
引用总数
学术搜索中的文章
JP Vandenbroucke, J Rosing, KWM Bloemenkamp… - New England Journal of Medicine, 2001